The AHNAK-53BP1 complex has been shown to suppress p53 target gene networks in multiple cancer types; meanwhile, AHNAK also directly interacts with p53 and inhibits p53-mediated target gene expression [27]. The gene discussed is TP53; the disease is cancer.